Global Health Limited Share Price

Equities

MEDANTA

INE474Q01031

Healthcare Facilities & Services

End-of-day quote NSE India S.E. 23:00:00 20/06/2024 BST 5-day change 1st Jan Change
1,329 INR +0.65% Intraday chart for Global Health Limited -2.03% +38.53%

Financials

Sales 2024 32.75B 393M 30.98B Sales 2025 * 38.35B 460M 36.27B Capitalization 357B 4.28B 337B
Net income 2024 4.78B 57.32M 4.52B Net income 2025 * 6.15B 73.76M 5.82B EV / Sales 2024 10.8 x
Net cash position 2024 * 7.08B 84.85M 6.7B Net cash position 2025 * 9.7B 116M 9.17B EV / Sales 2025 * 9.05 x
P/E ratio 2024
74.2 x
P/E ratio 2025 *
57.5 x
Employees 7,829
Yield 2024 *
0.21%
Yield 2025 *
0.25%
Free-Float 31.93%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.65%
1 week-2.03%
Current month+11.48%
1 month+10.56%
3 months+3.76%
6 months+36.44%
Current year+38.53%
More quotes
1 week
1 296.00
Extreme 1296
1 388.95
1 month
1 026.05
Extreme 1026.05
1 388.95
Current year
938.45
Extreme 938.45
1 513.90
1 year
646.85
Extreme 646.85
1 513.90
3 years
390.55
Extreme 390.55
1 513.90
5 years
390.55
Extreme 390.55
1 513.90
10 years
390.55
Extreme 390.55
1 513.90
More quotes
Managers TitleAgeSince
Chief Executive Officer - 30/11/10
78 -
Chief Tech/Sci/R&D Officer - 05/11/14
Members of the board TitleAgeSince
Director/Board Member 64 07/07/21
Director/Board Member 67 22/03/21
Chairman 78 -
More insiders
Date Price Change Volume
21/06/24 1,329 +0.65% 309,502
20/06/24 1,320 -2.31% 697,126
19/06/24 1,351 -1.61% 245,238
18/06/24 1,373 +1.27% 429,780

End-of-day quote NSE India S.E., June 20, 2024

More quotes
Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare, and telemedicine services. It provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others. Its facilities and services include medicine delivery, lab tests & diagnostics, book homecare services and others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
1,329 INR
Average target price
1,376 INR
Spread / Average Target
+3.57%
Consensus
  1. Stock Market
  2. Equities
  3. MEDANTA Stock